BIOMAR GROUP A/S - Group

 

Quicksearch
from your own companies




Analyst: XBRLDenmarkIFRS
Estimate generation in progress, please wait...
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.8% 1.3% 1.3% 1.4% 1.0%  
Credit score (0-100)  93 80 78 78 86  
Credit rating  AA A A A A  
Credit limit (mDKK)  310.2 42.5 40.3 34.9 239.1  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (mDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  11,180 11,649 13,300 17,861 17,878  
Gross profit  1,482 1,464 892 1,037 1,259  
EBITDA  709 642 889 957 1,214  
EBIT  709 642 540 602 860  
Pre-tax profit (PTP)  675.9 538.3 539.5 709.3 654.2  
Net earnings  540.6 396.2 397.8 555.5 483.5  
Pre-tax profit without non-rec. items  676 538 539 709 654  

 
See the entire income statement

Balance sheet (mDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  1,745 1,625 1,683 1,743 1,716  
Shareholders equity total  2,857 2,664 2,917 3,190 3,125  
Interest-bearing liabilities  2,565 2,258 2,820 3,635 3,729  
Balance sheet total (assets)  8,776 8,509 10,004 11,705 11,181  

Net Debt  2,295 1,965 2,558 3,336 3,545  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  11,180 11,649 13,300 17,861 17,878  
Net sales growth  8.3% 4.2% 14.2% 34.3% 0.1%  
Gross profit  1,482 1,464 892 1,037 1,259  
Gross profit growth  15.8% -1.2% -39.0% 16.2% 21.5%  
Employees  0 0 1,463 1,589 1,613  
Employee growth %  0.0% 0.0% 0.0% 8.6% 1.5%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  8,776 8,509 10,004 11,705 11,181  
Balance sheet change%  22.9% -3.0% 17.6% 17.0% -4.5%  
Added value  708.8 641.8 889.4 952.1 1,214.4  
Added value %  6.3% 5.5% 6.7% 5.3% 6.8%  
Investments  472 -254 -151 -133 -486  

Net sales trend  3.0 4.0 5.0 5.0 5.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  6.3% 5.5% 6.7% 5.4% 6.8%  
EBIT %  6.3% 5.5% 4.1% 3.4% 4.8%  
EBIT to gross profit (%)  47.8% 43.9% 60.5% 58.1% 68.3%  
Net Earnings %  4.8% 3.4% 3.0% 3.1% 2.7%  
Profit before depreciation and extraordinary items %  4.8% 3.4% 5.6% 5.1% 4.7%  
Pre tax profit less extraordinaries %  6.0% 4.6% 4.1% 4.0% 3.7%  
ROA %  9.5% 7.2% 6.6% 8.0% 8.1%  
ROI %  15.5% 12.0% 11.4% 13.8% 13.6%  
ROE %  19.9% 14.4% 15.3% 21.1% 17.7%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  32.6% 31.3% 29.2% 27.3% 28.0%  
Relative indebtedness %  52.9% 50.2% 53.3% 47.7% 45.1%  
Relative net indebtedness %  50.5% 47.7% 51.3% 46.0% 44.0%  
Net int. bear. debt to EBITDA, %  323.8% 306.2% 287.6% 348.5% 291.9%  
Gearing %  89.8% 84.7% 96.7% 113.9% 119.3%  
Net interest  0 0 0 0 0  
Financing costs %  4.0% 3.4% 2.9% 5.1% 7.5%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.6 0.6 0.6 0.5 0.6  
Current Ratio  0.9 0.9 0.9 0.9 0.9  
Cash and cash equivalent  269.8 292.8 261.7 298.9 183.8  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  40.4% 40.3% 43.0% 40.1% 38.6%  
Net working capital  -452.7 -356.0 -779.0 -831.8 -721.2  
Net working capital %  -4.0% -3.1% -5.9% -4.7% -4.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 9 11 11  
Added value / employee  0 0 1 1 1  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 1 1 1  
EBIT / employee  0 0 0 0 1  
Net earnings / employee  0 0 0 0 0